KoBioLabs, Inc (KOSDAQ:348150)
South Korea
· Delayed Price · Currency is KRW 5,530.00
+70.00 (1.28%)
At close: Dec 5, 2025
KoBioLabs Revenue
KoBioLabs had revenue of 19.26B KRW in the quarter ending September 30, 2025, with 13.88% growth. This brings the company's revenue in the last twelve months to 71.83B, up 17.19% year-over-year. In the year 2024, KoBioLabs had annual revenue of 68.36B with 106.28% growth.
Revenue (ttm)
71.83B
Revenue Growth
+17.19%
P/S Ratio
1.50
Revenue / Employee
n/a
Employees
n/a
Market Cap
107.39B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |
| KB Financial Group | 14.89T |